Skip to content

Optimizing Sleep Health in Nurses

Piloting an Adaption of Cognitive Behavioral Therapy for Insomnia for Shift Workers (CBTI-Shift)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05965609
Acronym
OSHIN
Enrollment
60
Registered
2023-07-28
Start date
2023-12-08
Completion date
2026-03-03
Last updated
2026-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circadian Rhythm Sleep-Wake Disorders, Shift Work Type, Sleep Initiation and Maintenance Disorders

Keywords

insomnia, shift work, circadian rhythm, sleep psychology, behavioral sleep medicine

Brief summary

The aim of the proposed study is to pilot test two behavioral sleep intervention strategies for improving insomnia among night shift working nurses.

Detailed description

Night shift nurses with insomnia who meet all study criteria will receive one of two insomnia therapies. The specific therapy for insomnia will be determine by chance (like a flip of a coin), with an equal chance to receive either cognitive-behavioral therapy for insomnia or multicomponent relaxation therapy for insomnia, both modified for shift workers. Both therapies will be conducted over telehealth by interventionists trained in behavioral sleep medicine.

Interventions

BEHAVIORALCBTI

Intervention includes education about sleep and behavioral and cognitive strategies to improve sleep

BEHAVIORALMRTI

Intervention includes education about sleep and behavioral and relaxation strategies to improve sleep

Sponsors

Oregon State University
Lead SponsorOTHER
American Academy of Sleep Medicine
CollaboratorOTHER
Monash University
CollaboratorOTHER
Stanford University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Participants are asked to refrain from mentioning any information about the treatment they receive when interacting with the investigator or outcomes assessors. Participants are asked not to share details of their treatment with other individuals at their workplace.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Current shift working nursing staff in Oregon * Expect to continue on shift work schedule during the study * Meets criteria for an insomnia disorder * Elevated insomnia symptoms * Have daily access to internet on a smartphone, tablet, or computer; and * Can read and write in English

Exclusion criteria

* People with uncontrolled medical conditions * Presence of safety risk or condition in which study participation may be ineffective or result in increased risk to safety * Some current treatments for insomnia * Permanent day, evening, or rotating shift schedule * History of seizures or manic episode; or * Current/expected pregnancy during the study period

Design outcomes

Primary

MeasureTime frameDescription
Change in Insomnia Severity IndexAt baseline and at the post-treatment assessment (occurring at approximately 10 weeks)Validated questionnaire; total score range between 0 and 28, with higher numbers representing greater insomnia severity
Retention RateAt the post-treatment assessment (occurring at approximately 10 weeks)Defined as \[number of participants who complete minimal therapeutic dose (at least 4 sessions)\] / \[number of randomized participants in treatment arm\]
Session AttendanceAt the post-treatment assessment (occurring at approximately 10 weeks)For enrolled participants, attendance rates will be calculated as \[number of visits attended\] / \[number of total visits\]
Implementation Assessment MeasureAt the post-treatment assessment (occurring at approximately 10 weeks)Validated questionnaire; total score range between 12 and 60, with higher numbers representing greater feasibility, acceptability, and appropriateness.

Secondary

MeasureTime frameDescription
Change in Fatigue Severity ScaleAt baseline and at the post-treatment assessment (occurring at approximately 10 weeks)Validated questionnaire; total score range between 9 and 63, with higher numbers representing greater fatigue.
Change in PROMIS Sleep Related Impairment 8 itemAt baseline and at the post-treatment assessment (occurring at approximately 10 weeks)Validated questionnaire; total score range between 8-40, with higher numbers indicating greater sleep-related wake time impairment

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJessica Dietch, PhD

Oregon State University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 7, 2026